ArticleNPJ Parkinson's disease2025
Preclinical and clinical study on type 3 metabotropic glutamate receptors in Parkinson's disease.
Luisa Di Menna et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
3 papers cite it
this papercites it